谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

328Tip Phase III Study of Trastuzumab Deruxtecan (T-Dxd) with or Without Pertuzumab Vs a Taxane, Trastuzumab and Pertuzumab in First-Line (1L), Human Epidermal Growth Factor Receptor 2–positive (HER2+) Metastatic Breast Cancer (mbc): DESTINY-Breast09

S.M. Tolaney,R. Barroso-Sousa, Z. Jiang,Y.H. Park,M. Rimawi,C. Saura Manich,A. Schneeweiss,M. Toi,T. Yu,J. Shetty,P. Herbolsheimer,S. Loibl

Annals of Oncology（2021）

引用 7|浏览0
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要